Special Issue "Advantages and Disadvantages of Electronic Cigarettes"

A special issue of Toxics (ISSN 2305-6304). This special issue belongs to the section "Toxicology".

Deadline for manuscript submissions: 31 December 2021.

Special Issue Editors

Prof. Dr. Andrzej Sobczak
E-Mail Website
Guest Editor
Department of General and Inorganic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, Poland
Interests: tobacco harm reduction; global health; e-cigarettes; nicotine; toxicology of tobacco smoke; vaping; biomarkers
Dr. Leon Kośmider
E-Mail Website
Guest Editor
Department of General and Inorganic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, Poland
Interests: e-cigarettes; nicotine; toxicants; smoking cessation; analytical chemistry of biomarkers

Special Issue Information

Dear colleagues,

Electronic cigarettes (ECs) have been present on the consumer market for over a decade, and the number of scientific publications in the PubMed database has now exceeded seven thousand. Despite the number of publications, there is still no consensus in the scientific community about their safety. However, it should be emphasized that a comparison of the equivalent quantities of tobacco smoke and the aerosol produced from e-cigarettes shows a significantly lower quantity of toxic compounds in the aerosol compared with tobacco smoke. This can be seen as a way of reducing the health damage to cigarette smokers who cannot or are unwilling to quit using conventional methods. In addition, randomized studies are emerging suggesting that ECs could be useful in smoking cessation. On the other hand, ECs are now widely used among adolescents, and may pose a serious risk of future nicotine dependence and health problems in this population, as they counteract the population’s gains from smokers who quit using them. Therefore, as most authors stress, further research is needed that will convincingly resolve the current controversies. Clinicians urgently need evidence-based knowledge to better inform their patients about the use of these emerging tobacco products as a harm-reduction strategy, and regulators to regulate these products in ways that best serve public health, especially taking the youth population into account.

For this Special Issue, we welcome a broad range of studies examining the health effects of ECs. In particular, we welcome original research articles or systematic reviews that focus on the following:

(1) Chemical composition of refill solutions and ECs’ aerosol.

(2) Studies on new tobacco/nicotine products, such as e-cigarettes, snus, and heat but not burn tobacco products in relation to the health impact of these products.

(3) Observational population studies on EC use.

(4) Intervention studies designed to prevent youths from starting to use smoked or smokeless tobacco, as well as studies designed to prevent nicotine addiction that may result from novel nicotine-containing products.

(5) Smoking cessation studies among adult smokers, including studies of novel approaches to smoking cessation. Of special interest are studies that demonstrate the potential efficacy of using vaporized nicotine products, including e-cigarettes, as a type of nicotine replacement for addicted smokers who want to quit.

Prof. Dr. Andrzej Sobczak
Dr. Leon Kośmider
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • e-cigarettes
  • global health
  • vaping
  • tobacco smoke
  • toxicants
  • cessation

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Open AccessArticle
Cross-Sectional Associations of Smoking and E-cigarette Use with Self-Reported Diagnosed Hypertension: Findings from Wave 3 of the Population Assessment of Tobacco and Health Study
Toxics 2021, 9(3), 52; https://doi.org/10.3390/toxics9030052 - 09 Mar 2021
Viewed by 445
Abstract
Following their introduction a decade ago, electronic cigarettes (e-cigarettes) have grown in popularity. Given their novelty, knowledge of the health consequences of e-cigarette use remains limited. Epidemiologic studies have not comprehensively explored associations between e-cigarette use and hypertension, a highly prevalent health condition [...] Read more.
Following their introduction a decade ago, electronic cigarettes (e-cigarettes) have grown in popularity. Given their novelty, knowledge of the health consequences of e-cigarette use remains limited. Epidemiologic studies have not comprehensively explored associations between e-cigarette use and hypertension, a highly prevalent health condition and major contributor to cardiovascular disease burden. In this study, cross-sectional associations of cigarette smoking and e-cigarette use (vaping) with self-reported diagnosed hypertension were evaluated among 19,147 18–55 year old respondents in Wave 3 (2015–2016) of the Population Assessment of Tobacco and Health Study. Multivariable analyses first modeled smoking and vaping as separate 2-category variables, then as a 6-category composite variable accounting for former smoking. After adjusting for potential confounders, current vaping (aOR = 1.31; 95%CI: 1.05–1.63) and current smoking (aOR = 1.27; 95%CI: 1.10–1.47) were both associated with higher odds of hypertension. In analyses modeling smoking and vaping compositely, respondents who were concurrently smoking and vaping had the highest odds of hypertension (aOR = 1.77; 95%CI: 1.32–2.39 [referent: never smokers]). These results differ somewhat from prior epidemiologic studies of vaping and respiratory outcomes, which consistently report smaller point estimates for current vaping than for current smoking. Our findings reinforce the uncertainty surrounding long-term health consequences of vaping, as well as highlight important distinctions between respiratory and cardiovascular outcomes when considering the harm reduction potential of e-cigarettes. Full article
(This article belongs to the Special Issue Advantages and Disadvantages of Electronic Cigarettes)
Show Figures

Figure 1

Back to TopTop